HealthDay News — The US Food and Drug Administration (FDA) has approved the first generic version of Tamiflu®.
Tamiflu (oseltamivir phosphate) is used to treat patients 2 weeks of age and older who have had flu symptoms for no more than 48 hours. It is also used for the prevention of flu in patients 1 year of age and older. The FDA approved Tamiflu in 1999.
Oseltamivir phosphate does not take the place of seasonal flu vaccination, the FDA emphasized.
The agency also said oseltamivir phosphate does not treat or prevent illnesses caused by infections other than the flu virus and does not prevent bacterial infections that may occur with the flu.
The FDA approves first generic version of widely used influenza drug, Tamiflu. Food and Drug Administration website. Updated August 4, 2016. Available at: http://www.fda.gov/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsand providers/ucm514854.htm. Accessed August 15, 2016.